2021年 業績

英文論文

• Ito K, Okumura A, S Takeuchi J, Watashi K, Inoue R, Yamauchi T, Sakamoto K, Yamashita Y, Iguchi Y, Une M, Wakita T, Umezawa K, Yoneda M. Dual Agonist of Farnesoid X Receptor and G Protein-coupled Receptor TGR5 Inhibits Hepatitis B Virus Infection in Vitro and in Vivo. Hepatology. 2021 Jan 12. doi: 10.1002/hep.31712. Epub ahead of print. PMID: 33434356.
• Sumida Y, Yoneda M, Tokushige K, Kawanaka M, Fujii H, Yoneda M, Imajo K, Takahashi H, Eguchi Y, Ono M, Nozaki Y, Hyogo H, Koseki M, Yoshida Y, Kawaguchi T, Kamada Y, Okanoue T, Nakajima A, Japan Study Group Of Nafld Jsg-Nafld. FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic. Life (Basel). 2021 Feb 14;11(2):143. doi: 10.3390/life11020143. PMID: 33672864; PMCID: PMC7917687.
• Nakade Y, Kitano R, Sakamoto K, Kimoto S, Yamauchi T, Inoue T, Kobayashi Y, Ohashi T, Sumida Y, Ito K, Yoneda M. Characteristics of bile acid composition in high fat diet-induced nonalcoholic fatty liver disease in obese diabetic rats. PLoS One. 2021 Feb 24;16(2):e0247303. doi: 10.1371/journal.pone.0247303. PMID: 33626072; PMCID: PMC7904175.
• Inoue T, Ibusuki M, Kitano R, Kobayashi Y, Ito K, Yoneda M. EUS-guided hepaticoduodenostomy combined with antegrade metal stenting using an ultrathin flexible delivery system. Endosc Int Open. 2021 Mar;9(3):E417-E418. doi: 10.1055/a-1326-1611. Epub 2021 Feb 19. PMID: 33655042; PMCID: PMC7895658.
• Kitano R, Inoue T, Ibusuki M, Kobayashi Y, Ohashi T, Sumida Y, Nakade Y, Ito K, Yoneda M. Safety and Efficacy of Endoscopic Retrograde Cholangiopancreatography in Patients with Performance Status 4. Dig Dis Sci. 2021 Apr;66(4):1291-1296. doi: 10.1007/s10620-020-06339-7. Epub 2020 May 21. PMID: 32440744.
• Inoue T, Ibusuki M, Kitano R, Kobayashi Y, Ohashi T, Sumida Y, Nakade Y, Ito K, Yoneda M. Radial incision and cutting combined with balloon dilation for refractory pancreaticojejunostomy anastomotic strictures. Endosc Int Open. 2021 Apr;9(4):E578-E582. doi: 10.1055/a-1372-3628. Epub 2021 Apr 12. PMID: 33860075; PMCID: PMC8041570.
• Nakade Y, Kitano R, Yamauchi T, Kimoto S, Sakamoto K, Inoue T, Kobayashi Y, Ohashi T, Sumida Y, Ito K, Yoneda M. Effect of Central Corticotropin-Releasing Factor on Hepatic Lipid Metabolism and Inflammation-Related Gene Expression in Rats. Int J Mol Sci. 2021 Apr 11;22(8):3940. doi: 10.3390/ijms22083940. PMID: 33920431; PMCID: PMC8069855.
• Inoue T, Kitano R, Ibusuki M, Kobayashi Y, Ito K, Yoneda M. Simultaneous triple stent-by-stent deployment following endobiliary radiofrequency ablation for malignant hilar biliary obstruction. Endoscopy. 2021 May;53(5):E162-E163. doi: 10.1055/a-1224-3698. Epub 2020 Aug 20. PMID: 32818988.
• Inoue T, Kitano R, Yoneda M. Endobiliary radiofrequency ablation for ingrowth occlusion after bilateral metal stent placement in patients with malignant hilar biliary obstruction. Endosc Int Open. 2021 Jun;9(6):E907-E908. doi: 10.1055/a-1396-4182. Epub 2021 May 27. PMID: 34079875; PMCID: PMC8159584.
• Inoue T, Ibusuki M, Kitano R, Kobayashi Y, Ito K, Yoneda M. Single-operator metal stent deployment for malignant biliary obstruction using a novel thumbwheel delivery system. Endoscopy. 2021 Jun 8. doi: 10.1055/a-1499-6512. Epub ahead of print. PMID: 34102675.
• Inoue T, Ibusuki M, Kitano R, Sakamoto K, Kimoto S, Kobayashi Y, Ohashi T, Sumida Y, Nakade Y, Ito K, Yoneda M. Safety and Efficacy of Gemcitabine Plus Nab-Paclitaxel for Metastatic Pancreatic Cancer Patients Undergoing Biliary Stent Placement. Dig Dis Sci. 2021 Jun 14. doi: 10.1007/s10620-021-07098-9. Epub ahead of print. PMID: 34125338.
• Inoue T, Naitoh I, Suzuki Y, Okumura F, Haneda K, Kitano R, Yoshida M, Hayashi K, Yoneda M. Multi-center study of endoscopic revision after side-by-side metal stent placement for malignant hilar biliary obstruction. Dig Endosc. 2021 Jul;33(5):807-814. doi: 10.1111/den.13854. Epub 2020 Nov 11. PMID: 32997391.
• Inoue T, Kitano R, Yoneda M. Hyperkalemia after endobiliary radiofrequency ablation for malignant biliary obstruction. Dig Endosc. 2021 Jul;33(5):874-875. doi: 10.1111/den.13989. Epub 2021 Apr 21. PMID: 33829559.
• Inoue T, Kutsumi H, Ibusuki M, Yoneda M. Feasibility of balloon-based endobiliary radiofrequency ablation under cholangioscopy guidance in a swine model. Sci Rep. 2021 Jul 9;11(1):14254. doi: 10.1038/s41598-021-93643-5. PMID: 34244576; PMCID: PMC8270987.
• Inoue T, Kitano R, Yoneda M. Troubleshooting of reinterventions after stent-by-stent placement for malignant hilar biliary obstruction (with videos). Hepatobiliary Pancreat Dis Int. 2021 Jul 29:S1499-3872(21)00128-4. doi: 10.1016/j.hbpd.2021.07.005. Epub ahead of print. PMID: 34366196.
• Sumida Y, Yoneda M. COVID-19-associated liver injury (COVALI): role of hepatologists. J Gastroenterol. 2021 Aug;56(8):786-787. doi: 10.1007/s00535-021-01809-9. Epub 2021 Jul 2. PMID: 34212231; PMCID: PMC8249182.
• Inoue T, Ibusuki M, Kitano R, Sakamoto K, Kimoto S, Kobayashi Y, Ohashi T, Sumida Y, Nakade Y, Ito K, Yoneda M. Endobiliary Radiofrequency Ablation Using a Short-Type Balloon Enteroscope in Patients with Surgically Altered Anatomy. Dig Dis Sci. 2021 Aug 19. doi: 10.1007/s10620-021-07224-7. Epub ahead of print. PMID: 34410572.
• Inoue T, Kitano R, Yoneda M. Gastrointestinal: Pancreatic duct perforation following endoscopic intraductal radiofrequency ablation for pancreatic duct stricture. J Gastroenterol Hepatol. 2021 Nov 10. doi: 10.1111/jgh.15724. Epub ahead of print. PMID: 34761433.
• Sumida Y, Yoneda M, Seko Y, Takahashi H, Hara N, Fujii H, Itoh Y, Yoneda M, Nakajima A, Okanoue T; Japan Study Group of NAFLD (JSG-NAFLD). Role of vitamin E in the treatment of non-alcoholic steatohepatitis. Free Radic Biol Med. 2021 Dec;177:391-403. doi: 10.1016/j.freeradbiomed.2021.10.017. Epub 2021 Oct 29. PMID: 34715296.
• Inoue T, Yoneda M. Updated evidence on the clinical impact of endoscopic radiofrequency ablation in the treatment of malignant biliary obstruction. Dig Endosc. 2022 Jan;34(2):345-358. doi: 10.1111/den.14059. Epub 2021 Jul 16. PMID: 34107114.
• Yamamura S, Nakano D, Hashida R, Tsutsumi T, Kawaguchi T, Okada M, Isoda H,
  Takahashi H, Matsuse H, Eguchi Y, Sumida Y, Nakajima A, Gerber L, Younossi ZM,
  Torimura T. Patient-reported outcomes in patients with non-alcoholic fatty liver
  disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic
  fatty liver disease/non-alcoholic steatohepatitis. J Gastroenterol Hepatol. 2021
  Mar;36(3):629-636. doi: 10.1111/jgh.15172. Epub 2020 Jul 16. PMID: 32627871.
• Kamada Y, Takahashi H, Shimizu M, Kawaguchi T, Sumida Y, Fujii H, Seko Y,
  Fukunishi S, Tokushige K, Nakajima A, Okanoue T; Japan Study Group of NAFLD
  (JSG‐NAFLD). Clinical practice advice on lifestyle modification in the
  management of nonalcoholic fatty liver disease in Japan: an expert review. J
  Gastroenterol. 2021 Dec;56(12):1045-1061. doi: 10.1007/s00535-021-01833-9. Epub
  2021 Oct 31. PMID: 34718870.
• Eguchi Y, Wong G, Lee IH, Akhtar O, Lopes R, Sumida Y. Hepatocellular
  carcinoma and other complications of non-alcoholic fatty liver disease and non-
  alcoholic steatohepatitis in Japan: A structured review of published works.
  Hepatol Res. 2021 Jan;51(1):19-30. doi: 10.1111/hepr.13583. Epub 2020 Dec 9.
  PMID: 33091191.
• Kawamura N, Imajo K, Kalutkiewicz KJ, Nagai K, Iwaki M, Kobayashi T, Nogami
  A, Honda Y, Kessoku T, Ogawa Y, Higurashi T, Hosono K, Takahashi H, Yoneda M,
  Saito S, Aishima S, Toyoda H, Hayashi H, Sumida Y, Ehman RL, Nakajima A.
  Influence of liver stiffness heterogeneity on staging fibrosis in patients with
  nonalcoholic fatty liver disease. Hepatology. 2021 Dec 24. doi:
  10.1002/hep.32302. Epub ahead of print. PMID: 34951726.
• Iwaki M, Kessoku T, Ozaki A, Kasai Y, Kobayashi T, Nogami A, Honda Y, Ogawa
  Y, Imajo K, Yoneda M, Maeda A, Tanaka Y, Nakajima S, Ohno H, Usuda H, Kawanaka
  M, Kawaguchi T, Torimura T, Kage M, Hyogo H, Takahashi H, Eguchi Y, Aishima S,
  Wada K, Kobayashi N, Sumida Y, Saito S, Nakajima A. Gut microbiota composition
  associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty
  liver disease. J Gastroenterol Hepatol. 2021 Aug;36(8):2275-2284. doi:
  10.1111/jgh.15487. Epub 2021 Mar 29. PMID: 33709477.
• Tada T, Saibara T, Ono M, Takahashi H, Eguchi Y, Hyogo H, Kawanaka M, Kumada
  T, Toyoda H, Yasuda S, Nakajima A, Yoneda M, Tanaka S, Shimada K, Hoshino H,
  Aishima S, Kage M, Sumida Y. Predictive value of cytokeratin-18 fragment levels
  for diagnosing steatohepatitis in patients with nonalcoholic fatty liver
  disease. Eur J Gastroenterol Hepatol. 2021 Nov 1;33(11):1451-1458. doi:
  10.1097/MEG.0000000000002176. PMID: 34334708.